GLPG
Companies
NASDAQ
Galapagos NV Sponsored ADR
Health Care
$28.23
+$0.73 (+2.65%)
Price Chart
Overview
About GLPG
Galapagos NV is a clinical-stage biotechnology company specialized in the discovery and development of small molecule medicines with novel modes of action.
Market Cap
$1.8B
Volume
5.0M
Avg. Volume
5.1M
P/E Ratio
-22.35577
Dividend Yield
0.00%
Employees
975.0
Company Information
Latest News for GLPG
Risk & Correlation Analysis
Market Correlation
0.79
Moderate Correlation
Volatility
Medium (0.32)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Low Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, GLPG shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$1.8B
Volume5.0M
P/E Ratio-22.36
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
October 31, 2024Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025